Developing a test to help treat leukaemia that has spread to the brain
Developing leukaemic biomarkers to enable personalised CNS-directed therapy
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Developing leukaemic biomarkers to enable personalised CNS-directed therapy
Ordering of driver mutations in bilateral Wilms’ tumour
Histopathology of lymphomas in children with primary immune deficiency
Investigating the arginine auxotrophy of paediatric brain tumours
Comprehensive molecular characterization of paediatric spinal ependymomas
Molecular profiling of relapsing craniopharyngioma
Investigation of ganglioside-specific receptor expression by tumour-infiltrating immune cells
Analysis of genome-wide 5-hydroxymethylcytosine patterns in human hepatoblastoma tumours during chemotherapy treatment
Defining the tumour microenvironment in extramedullary acute leukaemia